Literature DB >> 35788371

Introduction to the Supplement: Is Now the Time for the Future of Cancer Economics Research?

Michael T Halpern1.   

Abstract

The National Cancer Institute's Division of Cancer Control and Population Sciences hosted a virtual conference, The Future of Cancer Health Economics Research, in December 2020. This conference brought together a multidisciplinary group of researchers and other stakeholders interested in supporting and developing the field of cancer health economics research to help improve both patient outcomes and health-care systems. The introduction to the supplement describes the origins and planning for the conference and the conference sessions and presentations. The papers included in this supplement, arising from the conference sessions, help strengthened our understanding of what is cancer health economics research and how this field can provide even greater contributions in the future. Published by Oxford University Press 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Year:  2022        PMID: 35788371      PMCID: PMC9255926          DOI: 10.1093/jncimonographs/lgab017

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  3 in total

1.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.

Authors:  Reshma Jagsi; John A E Pottow; Kent A Griffith; Cathy Bradley; Ann S Hamilton; John Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

2.  A framework for cancer health economics research.

Authors:  Michael T Halpern; Ya-Chen Tina Shih; K Robin Yabroff; Donatus U Ekwueme; Cathy J Bradley; Amy J Davidoff; Lindsay M Sabik; Joseph Lipscomb
Journal:  Cancer       Date:  2020-11-25       Impact factor: 6.921

3.  Medical Care Costs Associated with Cancer Survivorship in the United States.

Authors:  Angela B Mariotto; Lindsey Enewold; Jingxuan Zhao; Christopher A Zeruto; K Robin Yabroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06-10       Impact factor: 4.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.